These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20801543)

  • 41. Impact of variation in patient response on model-based control of glycaemia in critically ill patients.
    Le Compte AJ; Pretty CG; Lin J; Shaw GM; Lynn A; Chase JG
    Comput Methods Programs Biomed; 2013 Feb; 109(2):211-9. PubMed ID: 21940063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain mass estimation by head circumference and body mass methods in neonatal glycaemic modelling and control.
    Gunn CA; Dickson JL; Pretty CG; Alsweiler JM; Lynn A; Shaw GM; Chase JG
    Comput Methods Programs Biomed; 2014 Jul; 115(2):47-54. PubMed ID: 24755066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortisol response to critical illness: effect of intensive insulin therapy.
    Vanhorebeek I; Peeters RP; Vander Perre S; Jans I; Wouters PJ; Skogstrand K; Hansen TK; Bouillon R; Van den Berghe G
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3803-13. PubMed ID: 16868064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generalisability of a Virtual Trials Method for Glycaemic Control in Intensive Care.
    Dickson JL; Stewart KW; Pretty CG; Flechet M; Desaive T; Penning S; Lambermont BC; Benyo B; Shaw GM; Chase JG
    IEEE Trans Biomed Eng; 2018 Jul; 65(7):1543-1553. PubMed ID: 28358672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of protocol-based physiotherapy on insulin sensitivity and peripheral glucose metabolism in critically ill patients.
    Carbon NM; Engelhardt LJ; Wollersheim T; Grunow JJ; Spies CD; Märdian S; Mai K; Spranger J; Weber-Carstens S
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1045-1053. PubMed ID: 35075782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of sensor and measurement timing errors on model-based insulin sensitivity.
    Pretty CG; Signal M; Fisk L; Penning S; Le Compte A; Shaw GM; Desaive T; Chase JG
    Comput Methods Programs Biomed; 2014 May; 114(3):e79-86. PubMed ID: 24074543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol.
    Thomas F; Pretty CG; Fisk L; Shaw GM; Chase JG; Desaive T
    Biomed Eng Online; 2014 Apr; 13():43. PubMed ID: 24739335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving glycaemic control in a metabolically stressed patient in ICU.
    Perkins C
    Br J Nurs; 2004 Jun; 13(11):652-7. PubMed ID: 15218430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nutrition delivery, workload and performance in a model-based ICU glycaemic control system.
    Stewart KW; Chase JG; Pretty CG; Shaw GM
    Comput Methods Programs Biomed; 2018 Nov; 166():9-18. PubMed ID: 30415721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of Stochastic Targeted Blood Glucose Control Protocol by virtual trials in the Malaysian intensive care unit.
    Jamaludin UK; M Suhaimi F; Abdul Razak NN; Md Ralib A; Mat Nor MB; Pretty CG; Humaidi L
    Comput Methods Programs Biomed; 2018 Aug; 162():149-155. PubMed ID: 29903481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Model-based glycaemic control: methodology and initial results from neonatal intensive care.
    Dickson JL; Chase JG; Lynn A; Shaw GM
    Biomed Tech (Berl); 2017 Apr; 62(2):225-233. PubMed ID: 27811342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation.
    Uyttendaele V; Knopp JL; Davidson S; Desaive T; Benyo B; Shaw GM; Chase JG
    Biomed Eng Online; 2019 Oct; 18(1):102. PubMed ID: 31640720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of haemodialysis on insulin sensitivity of acute renal failure (ARF) patients with sepsis in critical care.
    Jamaludin UK; Docherty PD; Chase JG; Shaw GM
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():3503-6. PubMed ID: 24110484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating Increased EGP During Stress Response in Critically Ill Patients.
    Ormsbee JJ; Knopp JL; Chase JG
    J Diabetes Sci Technol; 2021 Jul; 15(4):856-864. PubMed ID: 32476457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examination of the association of steroids with fluid accumulation in critically ill patients, considering the possibility of biases.
    Frenkel A; Abuhasira R; Bichovsky Y; Bukhin A; Novack V; Brotfain E; Zlotnik A; Klein M
    Sci Rep; 2021 Mar; 11(1):5557. PubMed ID: 33692418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased insulin resistance in intensive care: longitudinal retrospective analysis of glycaemic control patients in a New Zealand ICU.
    Knopp JL; Chase JG; Shaw GM
    Ther Adv Endocrinol Metab; 2021; 12():20420188211012144. PubMed ID: 34123348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sepsis hyperglycemia in the ICU: from the mechanism to the clinic].
    Aleman L; Guerrero J
    Rev Med Chil; 2018 Apr; 146(4):502-510. PubMed ID: 29999126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A model-based control protocol for transition from ICU to HDU: Robustness analysis.
    Razak NN; Chase JG; Suhaimi FM; Shaw GM; Jamaluddin U
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():205-8. PubMed ID: 24109660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oatmeal interventions in severe insulin resistance on the intensive care unit: A case report.
    Storz MA; Helle P
    Complement Ther Med; 2019 Oct; 46():69-72. PubMed ID: 31519290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormones and the critically ill].
    Jäger F; Willenberg HS
    Dtsch Med Wochenschr; 2013 Apr; 138(14):697-9. PubMed ID: 23533032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.